The osteoporosis medication
strontium ranelate (SR) will once again be available in the UK from January
2019.
The drug was previously available under the brand Protelos but was pulled from the UK market in August 2017.
Servier, the manufacturer of the drug at the time, decided to cease supplying it to the UK due to loss of sales. Use of the drug in the UK had been limited by the health authorities due to safety concerns about cardiovascular risks. A continuous decline in the number of people being treated with it led to the company's decision.
Pharmaceutical company Aristo has now taken on the manufacturing of strontium ranelate, which will be available for prescription beginning January 2019, for the treatment of severe osteoporosis in postmenopausal women and adult men who are at high risk of fracture.
This is good news for UK patients who wish to take SR. It is also good news for those of us in the USA and Canada, where SR is not available, but strontium citrate (SC) is. Some people taking SC got scared when SR was pulled from the UK and the EU. I have continuously taken SC for 11 years. Below is a link to the package information for Aristo.
Package leaflet: Information for the
patient
Strontium ranelate Aristo 2 g
granules for oral suspension
Marketing Authorisation Holder
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
Manufacturer
Lindopharm GmbH
Neustraße 82
40721 Hilden
Germany